Harrow (HROW) delivered earnings and revenue surprises of -7.69% and +0.87%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Harrow (HROW) delivered earnings and revenue surprises of -7.69% and +0.87%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Ironwood (IRWD) delivered earnings and revenue surprises of +20.00% and -10.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Harrow (HROW) delivered earnings and revenue surprises of -47.83% and -0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Merck KGaA (MKKGY) delivered earnings and revenue surprises of -44.68% and +3.54%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +50.00% and +33.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -33.33% and -3.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Spring Valley Acquisition, 60 Degrees Pharmaceuticals, and Namib Minerals are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of...